Acceptance, attitudes, and beliefs of singaporean Chinese toward an ocular implant for glaucoma drug delivery

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8240-8245

  Foo, Reuben Chao Ming ^a   Lamoureux, Ecosse L ^b,c   Wong, Ryan C K ^d   Ho, Sue Wei ^c   Chiang, Peggy P C ^c   Rees, Gwyneth ^b   Aung, Tin ^a,c,d   Wong, Tina T ^a,c,d  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS;

ADULT; AGED; ARTICLE; BELIEFS ABOUT MEDICINES QUESTIONNAIRE; BRIEF ILLNESS PERCEPTION QUESTIONNAIRE; CHINESE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG IMPLANT; FEMALE; GLAUCOMA; HEALTH BELIEF; HEALTH CARE COST; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MODIFIED 8-ITEM MEDICATION ADHERENCE SCALE; OPHTHALMOLOGICAL IMPLANT; PATIENT ATTITUDE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIOECONOMICS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FEMALE; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SINGAPORE;

EID: 84873366075     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10393     Document Type: Article

References (37)

1. Pascolini D, Mariotti SP. Global estimates of visual impairment: Br J Ophthalmol. 2012;96:614-618.
2. Tsai JC, Kanner EM. Current and emerging medical therapies for glaucoma. Expert Opin Emerging Drugs. 2005;10:109-118.
3. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
4. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429-440.
5. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126: 498-505.
6. Sleath B, Robin AL, Covert D, et al. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113:431-436.
7. Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(suppl 1):S57-S68.
8. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48: 5052-5057.
9. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11 suppl):S30-S36.
10. Monem AS, Ali FM, Ismail MW. Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharm. 2000;198:29-38.
11. Natarajan JV, Ang M, Darwitan A, et al. Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. Int J Nanomedicine. 2012;7:123-131.
12. Natarajan JV, Chattopadhyay S, Ang M, et al. Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye. PLoS One. 2011;6: e24513.
13. De Campos AM, Sanchez A, Gref R, et al. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci. 2003;20: 73-81.
14. Hiratani H, Alvarez-Lorenzo C. Timolol uptake and release by imprinted soft contact lenses made of N, N-diethylacrylamide and methacrylic acid. J Control Release. 2002;83:223-230.
15. Saati S, Lo R, Li PY, et al. Mini drug pump for ophthalmic use. Curr Eye Res. 2010;35:192-201.
16. Bertram J, Saluja SS, McKain JA, Lavik EB. Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/poly(lactic acid) microspheres for over 3 months. J Microencapsul. 2009; 26:18-26.
17. Natarajan JV, Ang M, Darwitan A, et al. Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. Int J Nanomedicine. 2012;7:123-131.
18. Natarajan JV, Chattopadhyay S, Ang M, et al. Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye. PLoS One. 2011;6: e24513.
19. Dankert ME, Brensinger CM, Metzger KL, et al. Attitudes of patients and family members towards implantable psychiatric medication. Schizophr Res. 2008;105:279-286.
20. Irani F, Dankert M, Brensinger C, et al. Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology. 2004;29:960-968.
21. Mills RP, Budenz DL, Lee PP, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24-30.
22. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1-24.
23. Broadbent E, Petrie KJ, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosom Res. 2006;60:631-637.
24. Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10:348-354.
25. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-567.
26. Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12: 393-398.
27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
28. Morisky DE, Ward HJ, Liu K-Y. Self-reported medication taking behavior: a valid indicator for assessing compliance [abstract 26352]. Presented at the 129th Meeting of the American Pharmacy Association, Atlanta, GA; October 21-25, 2001. Available: at https://apha.confex.com/apha/129am/ techprogram/paper_26352.htm. Accessed June 8, 2007.
29. Södergard B, Halvarsson M, Tully MP, et al. Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther. 2006;31:605-616.
30. Lamoureux E, Pesudovs K. Vision-specific quality-of-life research: a need to improve the quality. Am J Ophthalmol. 2011;151:195-197. e2.
31. Jampel HD, Schwartz GF, Robin AL, et al. Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol. 2003;121:540-546.
32. Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford). 2005;44:762-767.
33. Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64:47-54.
34. Muir KW, Lee PP. Health literacy and ophthalmic patient education. Surv Ophthalmol. 2010;55:454-459.
35. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794-811.
36. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
37. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.